Results 131 to 140 of about 11,904 (210)

Association between the use of anti-herpetic drugs and subsequent initiation of Alzheimer's disease drug treatment: Dutch population-based inception cohort study. [PDF]

BMJ Open
Alghamdi A, Balafas S, Bos JHJ, van Munster BC, Rafie K, Dolga AM, Hak E.   +6 more
europepmc   +1 more source

Antiglycative Properties of Anti-Dementia Drugs-In Vitro, In Silico Studies and a Systematic Literature Review. [PDF]

Antioxidants (Basel)
Orlof W, Ladny JR, Michalak D, Zendzian-Piotrowska M, Zalewska A, Maciejczyk M.   +5 more
europepmc   +1 more source

Rivastigmine versus placebo in hyperhomocysteinemic Parkinson\u27s disease dementia patients

The effects of rivastigmine versus placebo in Parkinson\u27s disease dementia (PDD) patients with elevated or normal/low plasma homocysteine were determined.
Barone P, Hsu C, van Laar T, Lane RM, Poewe W, Burn DJ   +5 more
core  

Cholinesterase Inhibitory Activity of Alkylated Quinobenzothiazinium Salts. [PDF]

Molecules
Stepankova S, Bak A, Latocha M, Kozik V, Kawulok A, Jampilek J, Zieba A.   +6 more
europepmc   +1 more source

The role of genetic polymorphisms on drug response in Alzheimer's disease: a systematic review. [PDF]

BMC Med Genomics
Climacosa FMM, Ornos EDB, Gapaz NCLL, Guantia MGR, Cruz JMC, Manalo RVM, Yu ML, Qureshi AP, Carampel AC, Asis JLB, Reyes JCB, Dacasin AB, Anlacan VMM.   +12 more
europepmc   +1 more source

Network meta-analysis of the efficacy of pharmacological treatments for post-stroke cognitive impairment and vascular cognitive impairment. [PDF]

Front Neurol
Li W, Liu X, Gao C, Li W, Liao X.
europepmc   +1 more source

Efficacy and safety of a novel, extended-release rivastigmine transdermal patch (TW-4752N) in patients with Alzheimer's disease: A 24-week randomized, double-blind trial with a 28-week open-label extension. [PDF]

J Alzheimers Dis
Nakamura Y, Kurokawa T, Terashima S, Nishimura A.   +3 more
europepmc   +1 more source

Discovery of ferulic acid carbamate derivatives as dual-targeting agents of BuChE and Nrf2 for Alzheimer's disease. [PDF]

J Enzyme Inhib Med Chem
Lao K, Li Y, Xiao Y, Sun Y, Dai Y, Li H, Yang Y, Zhang Y, Wang J, Li W, Gou X, Guan L.   +11 more
europepmc   +1 more source

BPC-157 and Its Novel Hybrid Analogs as Inhibitors of Acetylcholinesterase. [PDF]

Int J Mol Sci
Jelińska J, Józwiak M, Szeleszczuk Ł, Sikora K, Kamysz W, Kleczkowska P, Gackowski M, Grodner B.   +7 more
europepmc   +1 more source

Bridging the gap: Efficacy of combined therapies for cognitive, behavioral, and functional outcomes in Alzheimer's disease - results from a systematic review and network meta-analysis. [PDF]

J Alzheimers Dis
Boongird C, Anothaisintawee T, Tearneukit W, Wongpipathpong W, Suthutvoravut U, Thongpan M, Pongsettakul N, Attia J, McKay GJ, Rattanasiri S, Thakkinstian A.   +10 more
europepmc   +1 more source